Results 221 to 230 of about 3,741,108 (338)

Antibody development after three mRNA SARS-CoV-2 vaccinations in patients with systemic autoimmune rheumatic disease with and without treatment: an observational cohort study. [PDF]

BMJ Open
Simader E, Kartnig F, Tobudic S, Mrak D, Deimel T, Karonitsch T, Haslacher H, Perkmann T, Mitter G, Winkler S, Aletaha D, Blueml S, Mandl P.   +12 more
europepmc   +1 more source

Identifying prognostic targets in metastatic prostate cancer beyond AR

FEBS Open Bio, EarlyView.
Genome‐wide functional screens combined with a large gene expression database and clinical outcomes can identify new therapeutic vulnerabilities in prostate cancer. Eight potentially druggable targets demonstrated strong dependency in cell lines, were associated with worse prognosis clinically, and showed evidence of protein expression in prostate ...
Emily Feng, Eric Feng, Tracy Berg, Isabella S. Nguyen, Lilac G. Nguyen, William Chen, Meng Zhang, David Quigley, Marina Sharifi, Haolong Li, Ilsa Coleman, Peter S. Nelson, Martin Sjöström, Shuang G. Zhao   +13 more
wiley   +1 more source

⁸⁹Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism. [PDF]

EJNMMI Res
Huisman MC, Pouw JEE, Golla SSV, Huglo D, Morschhauser F, Zijlstra JM, Wijngaarden JE, Stavenga M, Sebus HJ, Slebe M, Thiele A, Vugts D, Miedema IHC, Zwezerijnen GJC, Bahce I, Menke-van der Houven van Oordt CW, Shah DK, Jauw YWS, Boellaard R.   +18 more
europepmc   +1 more source

Observations on a Qualitative Difference Between the Antibody of Primary and Secondary Response [PDF]

, 1957
W. D. Foster
openalex   +1 more source

Current trends in single‐cell RNA sequencing applications in diabetes mellitus

FEBS Open Bio, EarlyView.
Single‐cell RNA sequencing is a powerful approach to decipher the cellular and molecular landscape at a single‐cell resolution. The rapid development of this technology has led to a wide range of applications, including the detection of cellular and molecular mechanisms and the identification and introduction of novel potential diagnostic and ...
Seyed Sajjad Zadian, Khodakaram Jahanbin, Shekoofeh Nikooei, Marzieh Rostaminejad, Arezoo Rahimi, Pedram Abdizadeh, Behnam Alipoor   +6 more
wiley   +1 more source

Correlates of risk of respiratory syncytial virus disease: a prospective cohort study. [PDF]

Nat Commun
Frivold C, Cox SN, Starita L, Babu TM, Hoffman KL, Carone M, Lockwood CM, Kuntz JL, Mularski RA, Varga A, Han PD, Reed J, Piliper EA, Mohamed Bakhash SAK, Greninger AL, Clark E, Stone J, Grindstaff S, Boisvert CL, Yetz N, Lo NK, Hatchie TL, Marshall G, Wolock CJ, Feldstein LR, Weil AA, Englund JA, Naleway AL, Chu HY.   +28 more
europepmc   +1 more source

LABELING OF ANTIBODIES WITH FLUORESCENT AZO DYES [PDF]

, 1959
Walter R. Dowdle, P. Arne Hansen
openalex   +1 more source

Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor‐adapted non‐small cell lung cancer cell lines

FEBS Open Bio, EarlyView.
Phenotypic plasticity in a newly established set of EGFR inhibitor‐adapted NSCLC cell lines during adaptation and in established cell lines. Here, we introduce novel sublines of the EGFR‐mutant non‐small cell lung cancer (NSCLC) cell lines HCC827 and HCC4006 adapted to the EGFR kinase inhibitors gefitinib (HCC827rGEFI2μm, HCC4006rGEFI1μm), erlotinib ...
Tharsagini V. Nanthaprakash, Campbell W. Gourlay, Ina Oehme, Michelle D. Garrett, Jindrich Cinatl Jr, Mark N. Wass, Martin Michaelis   +6 more
wiley   +1 more source

Diagnostic Yield of Anti-Neuronal Antibody Testing in Patients Suspected of an Infectious Encephalitis. [PDF]

Eur J Neurol
Ter Horst L, Brenner J, van Zeggeren IE, IPACE Study Group, van de Beek D, Titulaer MJ, Brouwer MC.   +6 more
europepmc   +1 more source

The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies [PDF]

, 1953
David Pressman, Leonhard Korngold
openalex   +1 more source